Cannabis occupies an unusual place in public perception — treated by some as essentially harmless and by others as a dangerous drug, with the actual evidence sitting in a more specific, less dramatic middle ground that is worth understanding on its own terms.
How cannabis affects the brain
THC, its primary psychoactive component, binds to cannabinoid receptors that are part of the brain's own natural endocannabinoid system, which is normally involved in mood, appetite, memory, and pain regulation. This is why cannabis produces the range of effects it does — altered perception, relaxation, appetite changes, and impaired short-term memory during use.
Dependence is real, though the risk profile differs from other substances
Roughly one in ten people who use cannabis will develop a dependence pattern over their lifetime, rising to something closer to one in six among those who begin use in adolescence — a meaningfully elevated risk in that younger group specifically. This is a real, well-documented phenomenon, cannabis use disorder, involving tolerance, withdrawal symptoms on stopping, and continued use despite negative consequences — genuinely lower in prevalence than dependence risk for substances like alcohol or nicotine, but not zero, and not negligible in the adolescent-onset group.
Withdrawal is a real, underappreciated phenomenon
Contrary to a common assumption that cannabis has no withdrawal syndrome, regular heavy users who stop commonly experience irritability, anxiety, sleep disturbance, decreased appetite, and cravings, typically beginning within a day or two of stopping and persisting for one to two weeks. It is generally less physically dramatic than alcohol or opioid withdrawal, but it is a genuine factor in why some people find stopping harder than expected.
Why adolescent use is a genuinely different risk category
The brain continues significant structural development into the mid-twenties, particularly in regions governing judgment, impulse control, and emotional regulation. Regular cannabis use during this developmental window is associated, in a substantial body of research, with a higher risk of dependence, and some studies link heavy adolescent use with effects on memory, attention, and in some cases an increased risk of triggering psychotic symptoms in individuals with an underlying vulnerability. This age-specific risk is the strongest, most consistent argument for delaying use, independent of any broader debate about cannabis policy.
The psychosis connection specifically
Cannabis use, particularly heavy use of high-potency products and particularly during adolescence, is associated with an increased risk of psychotic symptoms and, in vulnerable individuals — including those with a personal or family history of psychotic illness — may contribute to triggering a first psychotic episode. This is not true for most users, but it is a genuine, evidence-supported risk in a specific, identifiable subgroup, and it is worth those individuals knowing this specifically applies to them.
What this means practically
Occasional adult use carries meaningfully different risk than regular heavy use, and use beginning in adulthood carries different risk than use beginning in adolescence. This is not a case for either alarm or dismissal — it is a case for the same thing I would say about any substance: the actual risk depends heavily on the pattern, the age of onset, and individual vulnerability factors, not on a single blanket statement in either direction.
This article is educational and does not replace individual medical care. If you are concerned about your own or a family member's cannabis use, or have a personal or family history of psychosis, a doctor or addiction service can help assess your specific situation.